A

ABL Bio Inc
KOSDAQ:298380

Watchlist Manager
ABL Bio Inc
KOSDAQ:298380
Watchlist
Price: 27 150 KRW 2.84% Market Closed
Market Cap: 1.3T KRW
Have any thoughts about
ABL Bio Inc?
Write Note
ABL Bio Inc
/
Balance Sheet
/
PP&E Net

ABL Bio Inc
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ABL Bio Inc
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
A
ABL Bio Inc
KOSDAQ:298380
PP&E Net
₩79.9B
CAGR 3-Years
157%
CAGR 5-Years
107%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
PP&E Net
₩1.2T
CAGR 3-Years
9%
CAGR 5-Years
6%
CAGR 10-Years
3%
SK Bioscience Co Ltd
KRX:302440
PP&E Net
₩315.9B
CAGR 3-Years
19%
CAGR 5-Years
13%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
PP&E Net
₩149.2B
CAGR 3-Years
19%
CAGR 5-Years
17%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
PP&E Net
₩146.1B
CAGR 3-Years
12%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
PP&E Net
₩19.3B
CAGR 3-Years
-14%
CAGR 5-Years
4%
CAGR 10-Years
N/A
No Stocks Found

ABL Bio Inc
Glance View

Market Cap
1.3T KRW
Industry
Biotechnology

ABL Bio, Inc. engages in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2018-12-19. The major products include anti-angiogenesis antibodies anti-tumor targeting antibodies, T cell engager bispecific antibodies (TCEs), dual immune cell targeting bispecific antibodies (DICs), novel immune cell targeting antibodies (NICs), brain disease dual antibodies, antibody-drug conjugates (ADCs) , among others.

Intrinsic Value
8 401.38 KRW
Overvaluation 69%
Intrinsic Value
Price
A
What is Intrinsic Value?

See Also

What is ABL Bio Inc's PP&E Net?
PP&E Net
79.9B KRW

Based on the financial report for Jun 30, 2024, ABL Bio Inc's PP&E Net amounts to 79.9B KRW.

What is ABL Bio Inc's PP&E Net growth rate?
PP&E Net CAGR 5Y
107%

Over the last year, the PP&E Net growth was 1 758%. The average annual PP&E Net growth rates for ABL Bio Inc have been 157% over the past three years , 107% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.